Abstract:
Differentiating Technologies Driving Disruptive Innovations in MedTech
The medical technology sector is undergoing a profound transformation toward decentralized care and continuous monitoring, demanding a new era of semiconductor foundations to turn disruptive concepts into clinical realities. Building on the strategic pillars of power efficiency, edge AI, and seamless connectivity, this talk explores the specialized architectures driving next-generation wearables and implantables. We will examine how ultra-low power CMOS platforms and advanced RF integration enable secure, real-time health data transmission. As devices require increasingly dense localized compute within constrained form factors, the discussion will also highlight broader industry trends in advanced packaging and heterogeneous integration that are essential for safely deploying high-performance processing in tomorrow's continuous-wear MedTech applications.
Biography:
Gregg Bartlett is Chief Technology Officer for GF, a position he was appointed to in 2022.
He leads the company’s core technology and GF Labs’ functions to drive innovation and long-range research and development portfolio by partnering with key universities and institutions for GF’s differentiated technology capabilities.
Prior to his current role, Mr. Bartlett has served in various senior executive roles at GF in technology and business since 2009. Before joining GF, Mr. Bartlett spent 25 years in technical and management positions at Freescale Semiconductor and Motorola. In support of the CHIPS and Science Act, Mr. Bartlett serves on the Industrial Advisory Committee. He represents GF on the Purdue Semiconductor Degree Program Leadership Board. He also serves on the Governing Council for SRC’s JUMP program. Mr. Bartlett serves as a member of the board of directors of Carbice Corporation.
Mr. Bartlett holds a bachelor’s degree in chemical engineering from Kansas State University.